Tag Archives: U.S.

Return-To-School Is Stressing Out U.S. Parents Across Income, Race and Political Party

The worse of the coronavirus pandemic is yet to come, most Americans felt in July 2020. That foreboding feeling is shaping U.S. parents’ concerns about their children returning to school, with the calendar just weeks away from educators opening their classrooms to students, from kindergarten to the oldest cohort entering senior year of high school.… Read More »

The Median Hospital Charge In the U.S. for COVID-19 Care Ranges From $34-45K

The median charge for hospitalizing a patient with COVID-19 ranged from $ 34,662 for people 23 to 30, and $ 45,683 for people between 51 and 60 years of age, according to FAIR Health’s research brief, Key Characteristics of COVID-19 Patients published July 14th, 2020. FAIR Health based these numbers on private insurance claims associated with… Read More »

Tremfya (guselkumab) Approved by U.S. Food and Drug Administration as the First Selective Interleukin (IL)-23 Inhibitor for Active Psoriatic Arthritis

Print this page HORSHAM, PA, July 14, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved Tremfya (guselkumab) for adult patients with active psoriatic arthritis (PsA), a chronic progressive disease characterized by painful joints and skin inflammation.[1],[2] Tremfya is the first treatment… Read More »

Hologic Releases SuperSonic MACH 40 Breast Ultrasound in U.S.

July 10th, 2020 Medgadget Editors Ob/Gyn, Oncology, Radiology Hologic is launching in the U.S. its first cart-based breast ultrasound system, the SuperSonic MACH 40. The company touts the device as a premium ultrasound that produces high fidelity images and features a number of capabilities that improve clinical efficiency and diagnostic accuracy. Some of these features… Read More »